A hybrid machine learning model combining association rule mining and classification algorithms to predict differentiated thyroid cancer recurrence.

associative classification differentiated thyroid cancer machine learning personalized medicine recurrence prediction

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2024
Historique:
received: 08 07 2024
accepted: 23 09 2024
medline: 21 10 2024
pubmed: 21 10 2024
entrez: 21 10 2024
Statut: epublish

Résumé

Differentiated thyroid cancer (DTC) is the most prevalent endocrine malignancy with a recurrence rate of about 20%, necessitating better predictive methods for patient management. This study aims to create a relational classification model to predict DTC recurrence by integrating clinical, pathological, and follow-up data. The balanced dataset comprises 550 DTC samples collected over 15 years, featuring 13 clinicopathological variables. To address the class imbalance in recurrence status, the Synthetic Minority Over-sampling Technique for Nominal and Continuous (SMOTE-NC) was utilized. A hybrid model combining classification algorithms with association rule mining was developed. Two relational classification approaches, regularized class association rules (RCAR) and classification based on association rules (CBAR), were implemented. Binomial logistic regression analyzed independent predictors of recurrence. Model performance was assessed through accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1 score. The RCAR model demonstrated superior performance over the CBAR model, achieving accuracy, sensitivity, and F1 score of 96.7%, 93.1%, and 96.7%, respectively. Association rules highlighted that papillary pathology with an incomplete response strongly predicted recurrence. The combination of incomplete response and lymphadenopathy was also a significant predictor. Conversely, the absence of adenopathy and complete response to treatment were linked to freedom from recurrence. Incomplete structural response was identified as a critical predictor of recurrence risk, even with other low-recurrence conditions. This study introduces a robust and interpretable predictive model that enhances personalized medicine in thyroid cancer care. The model effectively identifies high-risk individuals, allowing for tailored follow-up strategies that could improve patient outcomes and optimize resource allocation in DTC management.

Sections du résumé

Background UNASSIGNED
Differentiated thyroid cancer (DTC) is the most prevalent endocrine malignancy with a recurrence rate of about 20%, necessitating better predictive methods for patient management. This study aims to create a relational classification model to predict DTC recurrence by integrating clinical, pathological, and follow-up data.
Methods UNASSIGNED
The balanced dataset comprises 550 DTC samples collected over 15 years, featuring 13 clinicopathological variables. To address the class imbalance in recurrence status, the Synthetic Minority Over-sampling Technique for Nominal and Continuous (SMOTE-NC) was utilized. A hybrid model combining classification algorithms with association rule mining was developed. Two relational classification approaches, regularized class association rules (RCAR) and classification based on association rules (CBAR), were implemented. Binomial logistic regression analyzed independent predictors of recurrence. Model performance was assessed through accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and F1 score.
Results UNASSIGNED
The RCAR model demonstrated superior performance over the CBAR model, achieving accuracy, sensitivity, and F1 score of 96.7%, 93.1%, and 96.7%, respectively. Association rules highlighted that papillary pathology with an incomplete response strongly predicted recurrence. The combination of incomplete response and lymphadenopathy was also a significant predictor. Conversely, the absence of adenopathy and complete response to treatment were linked to freedom from recurrence. Incomplete structural response was identified as a critical predictor of recurrence risk, even with other low-recurrence conditions.
Conclusion UNASSIGNED
This study introduces a robust and interpretable predictive model that enhances personalized medicine in thyroid cancer care. The model effectively identifies high-risk individuals, allowing for tailored follow-up strategies that could improve patient outcomes and optimize resource allocation in DTC management.

Identifiants

pubmed: 39430590
doi: 10.3389/fmed.2024.1461372
pmc: PMC11486678
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1461372

Informations de copyright

Copyright © 2024 Firat Atay, Yagin, Colak, Elkiran, Mansuri, Ahmad and Ardigò.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Feyza Firat Atay (F)

Department of Internal Medicine and Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey.

Fatma Hilal Yagin (FH)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, Malatya, Turkey.

Cemil Colak (C)

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, Malatya, Turkey.

Emin Tamer Elkiran (ET)

Department of Internal Medicine and Medical Oncology, Faculty of Medicine, Inonu University, Malatya, Turkey.

Nasrin Mansuri (N)

Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.

Fuzail Ahmad (F)

Department of Respiratory Care, College of Applied Sciences, Almaarefa University, Diriya, Riyadh, Saudi Arabia.

Luca Paolo Ardigò (LP)

Department of Teacher Education, NLA University College, Oslo, Norway.

Classifications MeSH